Aceso Life Science Group Limited (0474.HK)
HKD 0.04
(0.0%)
HKD 0.04
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.78 Billion HKD | -24.04% |
| 2022 | 6.3 Billion HKD | 0.61% |
| 2021 | 6.26 Billion HKD | 1.59% |
| 2020 | 6.16 Billion HKD | 22.48% |
| 2019 | 5.03 Billion HKD | -9.38% |
| 2018 | 5.55 Billion HKD | 10.44% |
| 2017 | 5.02 Billion HKD | -5.87% |
| 2016 | 5.34 Billion HKD | -36.6% |
| 2015 | 8.42 Billion HKD | 36.09% |
| 2014 | 6.19 Billion HKD | 118.83% |
| 2013 | 2.83 Billion HKD | 5.24% |
| 2012 | 2.68 Billion HKD | -37.67% |
| 2011 | 4.31 Billion HKD | 57.19% |
| 2010 | 2.74 Billion HKD | 9.7% |
| 2009 | 2.5 Billion HKD | 1163.56% |
| 2008 | 198.02 Million HKD | -21.33% |
| 2007 | 251.72 Million HKD | 15.67% |
| 2006 | 217.62 Million HKD | 8.76% |
| 2005 | 200.09 Million HKD | 7.9% |
| 2004 | 185.43 Million HKD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q4 | 4.78 Billion HKD | 0.0% |
| 2023 Q1 | 5.3 Billion HKD | -15.87% |
| 2023 Q2 | 5.3 Billion HKD | 0.0% |
| 2023 Q3 | 4.78 Billion HKD | -9.72% |
| 2023 FY | 4.78 Billion HKD | -24.04% |
| 2022 Q4 | 6.3 Billion HKD | 0.0% |
| 2022 Q3 | 6.3 Billion HKD | 9.09% |
| 2022 FY | 6.3 Billion HKD | 0.61% |
| 2022 Q1 | 5.77 Billion HKD | -7.78% |
| 2022 Q2 | 5.77 Billion HKD | 0.0% |
| 2021 Q2 | 6.74 Billion HKD | 0.0% |
| 2021 FY | 6.26 Billion HKD | 1.59% |
| 2021 Q1 | 6.74 Billion HKD | 9.44% |
| 2021 Q4 | 6.26 Billion HKD | 0.0% |
| 2021 Q3 | 6.26 Billion HKD | -7.17% |
| 2020 Q3 | 6.16 Billion HKD | 20.15% |
| 2020 Q1 | 5.13 Billion HKD | 1.94% |
| 2020 FY | 6.16 Billion HKD | 22.48% |
| 2020 Q4 | 6.16 Billion HKD | 0.0% |
| 2020 Q2 | 5.13 Billion HKD | 0.0% |
| 2019 Q2 | 5.76 Billion HKD | 0.0% |
| 2019 FY | 5.03 Billion HKD | -9.38% |
| 2019 Q4 | 5.03 Billion HKD | -0.01% |
| 2019 Q3 | 5.03 Billion HKD | -12.65% |
| 2019 Q1 | 5.76 Billion HKD | 3.75% |
| 2018 Q1 | 5.27 Billion HKD | 4.89% |
| 2018 Q4 | 5.55 Billion HKD | 0.0% |
| 2018 Q3 | 5.55 Billion HKD | 5.29% |
| 2018 Q2 | 5.27 Billion HKD | 0.0% |
| 2018 FY | 5.55 Billion HKD | 10.44% |
| 2017 Q4 | 5.02 Billion HKD | 0.0% |
| 2017 FY | 5.02 Billion HKD | -5.87% |
| 2017 Q3 | 5.02 Billion HKD | 5.78% |
| 2017 Q2 | 4.75 Billion HKD | 0.0% |
| 2017 Q1 | 4.75 Billion HKD | -11.01% |
| 2016 Q2 | 7.22 Billion HKD | 0.0% |
| 2016 Q4 | 5.34 Billion HKD | 0.0% |
| 2016 Q3 | 5.34 Billion HKD | -26.09% |
| 2016 FY | 5.34 Billion HKD | -36.6% |
| 2016 Q1 | 7.22 Billion HKD | -14.22% |
| 2015 FY | 8.42 Billion HKD | 36.09% |
| 2015 Q3 | 8.42 Billion HKD | 13.88% |
| 2015 Q4 | 8.42 Billion HKD | 0.0% |
| 2015 Q2 | 7.4 Billion HKD | 0.0% |
| 2015 Q1 | 7.4 Billion HKD | 19.51% |
| 2014 Q2 | 5.22 Billion HKD | 0.0% |
| 2014 FY | 6.19 Billion HKD | 118.83% |
| 2014 Q4 | 6.19 Billion HKD | 0.0% |
| 2014 Q1 | 5.22 Billion HKD | 84.77% |
| 2014 Q3 | 6.19 Billion HKD | 18.43% |
| 2013 Q4 | 2.83 Billion HKD | 0.0% |
| 2013 FY | 2.83 Billion HKD | 5.24% |
| 2013 Q1 | 2.52 Billion HKD | -6.19% |
| 2013 Q2 | 2.52 Billion HKD | 0.0% |
| 2013 Q3 | 2.83 Billion HKD | 12.18% |
| 2012 Q2 | 2.84 Billion HKD | 0.0% |
| 2012 FY | 2.68 Billion HKD | -37.67% |
| 2012 Q1 | 2.84 Billion HKD | -34.0% |
| 2012 Q3 | 2.68 Billion HKD | -5.56% |
| 2012 Q4 | 2.68 Billion HKD | 0.0% |
| 2011 Q2 | 4.44 Billion HKD | 0.0% |
| 2011 Q4 | 4.31 Billion HKD | 0.0% |
| 2011 FY | 4.31 Billion HKD | 57.19% |
| 2010 Q4 | 2.74 Billion HKD | 0.0% |
| 2010 Q2 | 2.37 Billion HKD | 0.0% |
| 2010 FY | 2.74 Billion HKD | 9.7% |
| 2009 FY | 2.5 Billion HKD | 1163.56% |
| 2009 Q4 | 2.5 Billion HKD | 0.0% |
| 2008 FY | 198.02 Million HKD | -21.33% |
| 2007 FY | 251.72 Million HKD | 15.67% |
| 2006 FY | 217.62 Million HKD | 8.76% |
| 2005 FY | 200.09 Million HKD | 7.9% |
| 2004 FY | 185.43 Million HKD | 0.0% |